Clinical Trials Sponsored by Cerecin

Total 75 results

Cerecin

Completed

Study to Compare the Pharmacokinetics of Daily Administration of Tricaprilin on Ketone Body Production

Alzheimer Disease

United States
Cerecin

Completed

Taste-masking Study for Tricaprilin in Sensory Panelists (TMS)

Taste Profile Assessments

United States
Cerecin

Completed

Pharmacokinetics of Tricaprilin Including Food Effect on Ketone Body Production

Alzheimer Disease

Australia
Cerecin

Withdrawn

Medical Food Formulation Pharmacokinetic (PK) Study in Medium Chain Triglycerides

Alzheimer Disease
Cerecin

Withdrawn

AC-1204 Long-term Efficacy Response Trial (ALERT Protocol) (ALERT)

Alzheimer's Disease

United States
Cerecin

Completed

A Phase 1, Two-part, Randomized Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Liquid Formulation of Tricaprilin and Matching Placebo in Healthy Subjects

Alzheimer Disease

United States
Cerecin

Terminated

Tricaprilin Liquid Formulation PK Study

Alzheimer Disease

Australia
Cerecin

Withdrawn

A Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheimer's Disease With Optional Open Label Extension

Alzheimer's Disease
Cerecin

Completed

Safety of Three Formulations of Ketasyn Administered for 14 Days in Healthy Elderly

Alzheimer's Disease

United States
Cerecin

Not yet recruiting

Tricaprilin Phase 3 AD Study

Alzheimer Disease
Cerecin

Completed

Tricaprilin Phase 2 Pilot Study in Migraine

Migraine

Australia
Cerecin

Completed

AC-OLE-01-VA Tolerability Study in Healthy Participants Under Different Dosing Conditions

Alzheimer Disease

Australia
Cerecin

Active, not recruiting

Tricaprilin Infantile Spasms Pilot Study

Infantile Spasm

Singapore, Australia
Cerecin

Completed

AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext (NOURISH-AD)

Alzheimer's Disease

United States
Cerecin

Completed

Tricaprilin in Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

United States
Cerecin

Completed

Tricaprilin In Age-Associated Memory Impairment

Age-Associated Memory Impairment

United States
Cerecin

Completed

Study to Compare the Pharmacokinetics of Tricaprilin Formulations and a Placebo on Ketone Body Production

Alzheimer Disease

Australia
Cerecin

Completed

Retrospective Cohort Study Of The Efficacy Of Axona® (Medium Chain Triglycerides) In Patients With Alzheimer's Disease (ACT)

Alzheimer's Disease
Cerecin
Celerion

Completed

Evaluation of PK of AC-1204 Mixed in Water, AC-1202 Mixed in Water, and AC-1202 Mixed in Ensure® on Ketone Body Production

Healthy

United States
Cerecin
Celerion

Completed

Study to Compare the Pharmacokinetics of AC 1202 and Two Doses of AC-SD-01 on Ketone Body Production

Healthy

United States
Cerecin
Celerion

Completed

Evaluation of PK of Caprylic Triglyceride Oil, AC-1202, AC-1204, and Axona on Ketone Body Production

Healthy

United States
Cerecin
Celerion

Completed

Evaluation of PK of AC1204 v Caprylic Triglyceride Oil Incl Food Effect on Ketone Body Production

Healthy

United States
Kerecis Ltd.

Completed

Healing of Punch Graft Wounds. Comparative Study Between MariGen and Oasis: a Non-inferiority Study

Punch Biopsy Wounds | Healing Times

Iceland
Kerecis Ltd.

Completed

Viruxal Oral and Nasal Spray for Treating the Symptoms of COVID-19 (KONS-COVID19)

COVID-19

Iceland
Kerecis Ltd.

Not yet recruiting

Kerecis Real World Registry

Surgical Wound | Diabetic Foot Ulcer | Venous Leg Ulcer | Pressure Ulcer | Wounds | Soft Tissue Reinforcement
Kerecis Ltd.

Recruiting

Kerecis Case Registry for SurgiBind : Soft Tissue Reinforcement

Surgery-Complications

United States
Kerecis Ltd.

Completed

Use of Fish Skin Extracellular Matrix (ECM) to Facilitate Chronic Wound Healing

Pressure Ulcers | Venous Ulcers | Trauma-related Wound | Diabetic Ulcers | Chronic Ulcer of Foot

Iceland
Kerecis Ltd.

Recruiting

Prospective Case Registry for Wounds

Wound Healing Delayed

United States
Kerecis Ltd.

Active, not recruiting

Omega3 Wound Fish Skin Graft in the Treatment of DFUs

Diabetic Foot Ulcer

United States
Cerenis Therapeutics, SA

Completed

Exploratory Study of Plaque Regression (EXPRESS)

Heterozygous Familial Hypercholesterolemia

Canada
University of Miami
National Multiple Sclerosis Society; Cerecin

Completed

Caprylic Triglyceride for Treatment of Cognitive Impairments in Multiple Sclerosis

Relapsing Remitting MS | Secondary Progressive MS | Primary Progressive MS

United States
Cerenis Therapeutics, SA

Terminated

CER-001 Therapy as a Novel Approach to Treat Genetic Orphan Diseases (TANGO)

Familial Hypoalphalipoproteinemia

France, United States, Belgium, Canada, Israel, Italy, Netherlands
Cerenis Therapeutics, SA

Completed

Effect of CER-001 on Plaque Volume in Homozygous Familial Hypercholesterolemia (HoFH) Subjects (MODE)

Homozygous Familial Hypercholesterolemia

United States, Canada, Italy, Netherlands, United Kingdom
Cerenis Therapeutics, SA

Completed

Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial (CHI SQUARE)

Acute Coronary Syndrome

Canada, United States, France, Netherlands
Kerecis Ltd.
MedStar Health

Completed

Fish Skin Compared to Cadaver Skin as Temporary Cover for Full Thickness Burns (Kereburn)

Burns

United States
Alper Percin

Completed

The Effect of Vagus Nerve Stimulation on Temporomandibular Joint Dysfunction

Temporomandibular Joint Dysfunction Syndrome | Autonomic Nervous System Imbalance

Turkey
Akdeniz University
Ceren Kahraman

Completed

Diabetic Ketoacidosis Diagnosis and Management

Diabetic Ketoacidosis | Brain Edema | Metabolic Acidosis

Turkey
Lotus Clinical Research, LLC
CerSci Therapeutics

Unknown

Double-blind, Placebo-control, Study to Evaluate the Safety and Pharmacokinetics of CT-044 HCl, in Healthy Volunteers

Surgery | Pain, Acute | Acute Pain | Neuropathy

United States
Lotus Clinical Research, LLC
CerSci Therapeutics

Completed

Open-label, Crossover, Food Effect Study to Evaluate CT-044 in Healthy Human Volunteers

Surgery | Pain, Acute | Acute Pain | Neuropathy

United States
Kerecis Ltd.
Tufts University School of Dental Medicine

Completed

A Clinical Trial to Evaluate Kerecis Oral™ Compared to Autogenous Free Gingival Graft (AFGG) Tissue to Augment Gingival Soft Tissue and Wound Healing

Mucogingival Deformity - Insufficient Keratinized Tissue
Kerecis Ltd.
Joseph M. Still Research Foundation, Inc.

Recruiting

AFS Compared to AHC in Treatment of Necrotizing Fasciitis NF (NF)

Necrotizing Fasciitis

United States
University of Oulu
Oulu University Hospital; Cerenion Oy

Completed

EEG Slow Wave Activity in Hypoxic Brain Injury (BrainICU)

Cardiac Arrest | Hypoxic-Ischemic Encephalopathy

Finland
University of Oulu
South Carelia Central Hospital; Cerenion Oy

Recruiting

EEG Changes During Induction of Propofol Anesthesia (PropoStatus)

Anesthesia, General | Healthy Subjects

Finland
Balgrist University Hospital
Verein Pro Chiropraktik; Balgrist Foundation

Recruiting

Spinal Segment MRI Perfusion and Diffusion Response to Spinal Manipulation in Low Back Pain Patients

Pain, Back

Switzerland
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

Safety and Efficacy Study of NFC-1 in Subjects Aged 12-17 Years With 22q11.2DS & Associated Neuropsychiatric Conditions

22q11.2 Deletion Syndrome

United States
Rosa Aspalter
University Hospital Regensburg

Completed

Impact of Elimination or Reduction of Dietary Animal Proteins on Cancer Progression and Survival - A Pilot Study

Neoplasms

Austria
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

Efficacy and Safety of NFC-1 in Adolescents With Genetic Disorders Impacting mGluR and ADHD

Attention Deficit Disorder With Hyperactivity

United States
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

PART B: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and Without mGluR Mutations

Attention Deficit Hyperactivity Disorder

United States
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

A Non-interventional Study to Identify Children and Adolescents With ADHD and With or Without mGLuR Mutations

Attention Deficit Hyperactivity Disorder

United States
Aevi Genomic Medicine, LLC, a Cerecor company
Medgenics Medical Israel Ltd.

Terminated

TARGTEPO Treatment for Anemia in End Stage Renal Disease (ESRD) Patients Undergoing Peritoneal Dialysis (PD)

Anemia of End Stage Renal Disease

Israel

Clinical Trials Sponsored by Cerecin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations